Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, the crucial step in the formation of thrombus. It is administered intravenously. Because it can cause blood stagnation, it is important to monitor changes in hematocrit, activated partial thromboplastin time, international normalized ratio and blood pressure. This compound belongs to the class of organic compounds known as polypeptides. These are peptides containing ten or more amino acid residues.

Price Not Available 1 mg Bivalirudin Supplier Page
Trivial name Bivalirudin
Catalog Number TP-075CL
Alternative Name(s) Bivalirudin
Research Area Haemostasis and thrombosis
Molecular Formula C98H138N24O33
CAS# 128270-60-0
Purity >90%
Size 1 mg
Supplier Page
Additional Information For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.